Early Treatment of Language Impairment in Young Children With Autism Spectrum Disorder With Leucovorin Calcium
Phase 2
80
about 5.8 years
2.5–5
2 sites in AZ, NY
About this study
This trial is testing a treatment for children with autism spectrum disorder (ASD) who have language problems. The goal is to see if leucovorin calcium improves their language skills and other symptoms associated with ASD.
Based on ClinicalTrials.gov records.
What participants do
- 1.Placebo
- 2.Take Levoleucovorin Calcium
Participation effort
Estimated from trial records. Details can vary by site.
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Antidotes, Deterrents, and Toxicologic Agents
injection (Injection)
Secondary: Evaluate change in autism severity of specific symptoms, Evaluate the change in effects of autism symptoms most problematic to family members, Evaluate the change in social withdrawal autism symptoms, Evaluate the change in stereotypical autism symptoms, Evaluate the overall change in core autism symptoms of social communication, Evaluate the safety and tolerability of L-leucovorin calcium in young children with ASD
Psychiatry / Mental Health